2 Papers
3 Citations
Yanping Chen is an academic researcher from Johnson & Johnson Pharmaceutical Research and Development. The author has contributed to research in topics: Trifluoromethyl & Benzothiazine. The author has an hindex of 1, co-authored 2 publications.
Chat about Author
Papers
Regio- and diastereoselective ring-opening of (S)-(−)-2-(trifluoromethyl)oxirane with chiral 2,5-disubstituted tetrahydroquinolines in hexafluoro-2-propanol
Xun Li,Ronald K. Russell,Hongfeng Chen,Yongzheng Zhang,Scott A. Ballentine,Jan Spink,Shawn Branum,Fuqiang Liu,Yanping Chen,Thomas Joachim Landewald Rammeloo,Wim Albert Alex Aelterman,Kirk L. Sorgi,William V. Murray +12 more
TL;DR: In this paper, a cholesteryl ester transfer protein (CETP) inhibitor, hexafluoro-2-propanol, was prepared in quantitative isolated yield (>99%) with excellent chemical and optical purities.
3
Patent
Process for the preparation of tetrahydroquinolinyl, benzoxazine and benzothiazine derivatives
Kirk L. Sorgi,Fuqiang Liu,Yanping Chen,Hongfeng Chen,Patel Mitul N,Xun Li,Aihua Wang,Scott A. Ballentine,Derek A. Beauchamp,John-Michael Macphee,Thomas Joachim Landewald Rammeloo,Tim Joeri Vanhoegaerden +11 more
- 08 May 2008
TL;DR: In this article, a novel process for the preparation of tetrahydroquinolinyl derivatives useful as in the treatment of disorders and conditions modulated by the cholesteryl ester transfer protein (CETP) was proposed.